Results 11 to 20 of about 26,853 (215)
Journal of Advanced Pharmaceutical Technology & Research, 2016 Attention-deficit hyperactivity disorder (ADHD) is a common psychiatric disorder among preschool children but the number of controlled clinical trials regarding psychopharmacological treatment in this age group is limited.
Parvin Safavi +2 more
doaj +2 more sources
Reward‐enhancing effect of methylphenidate is abolished in dopamine transporter knockout mice: A model of attention‐deficit/hyperactivity disorder [PDF]
Neuropsychopharmacology Reports, 2018 Aim Attention‐deficit/hyperactivity disorder is a heterogeneous neurobiological disorder that is characterized by inattention, impulsivity, and an increase in motor activity.
Soichiro Ide +6 more
doaj +2 more sources
Severe self-limiting acute bilateral hearing loss following a low dose of methylphenidate for ADHD treatment: A case report. [PDF]
PCN RepPsychiatry and Clinical Neurosciences Reports, Volume 5, Issue 1, March 2026.
Zandifar A, Badrfam R.
europepmc +2 more sources
Epilepsy & Behavior Reports, 2021 We present data on a 10-year-old patient with drug-resistant epilepsy who was treated with methylphenidate for symptoms of attention deficit hyperactivity disorder (ADHD) that developed after she underwent surgical resection of a left frontal cortical ...
Donald J. Bearden +6 more
doaj +1 more source
Pharmaceuticals, 2021 Methylphenidate is one of the most widely used oral treatments for attention-deficit/hyperactivity disorder (ADHD). The drug is mainly absorbed in the small intestine and has low bioavailability.
Julia Aresti-Sanz +4 more
doaj +1 more source
Prevalence of methylphenidate use by university students in Campos dos Goytacazes, RJ
Vértices, 2014 Methylphenidate is a central nervous system stimulant commonly prescribed for children with Attention Deficit Hyperactivity Disorder. The aim of this study was to identify the prevalence of methylphenidate users among college students, as well as the ...
Fernanda Fraga Pessanha +1 more
doaj +1 more source
Journal of Research in Pharmacy Practice, 2014 Objective: The aim of the current study was to determine various aspects of methylphenidate adverse reactions in children with attention deficit-hyperactivity disorder (ADHD) in Iran.
Zahra Khajehpiri +5 more
doaj +1 more source
PLoS ONE, 2014 BackgroundCancer-related fatigue (CRF) is a common symptom affecting patients with cancer. There are an increasing number of trials examining potential treatments for CRF.
Shun Gong +7 more
doaj +1 more source
Frontiers in Psychiatry, 2022 ContextADHD is the most common mental disorder in school-aged children. In France, methylphenidate is the only drug authorized for ADHD. Here, we describe the pattern of ADHD diagnosis and methylphenidate prescription to children and adolescents from ...
Sébastien Ponnou, Benoît Thomé
doaj +1 more source
South African Family Practice, 2017 Background: The use of methylphenidate as cognitive enhancer is a growing trend among students at tertiary institutions globally. This study aimed to determine the prevalence of methylphenidate use and co-use with alcohol among on-campus residence ...
P M Van Zyl +7 more
doaj +1 more source